河南翔宇医疗设备股份有限公司

Core Points - The company has revised multiple governance documents and rules, all of which received unanimous approval from the board of directors [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41] - The company plans to hold its second extraordinary general meeting of shareholders in 2025 on November 24, with both on-site and online voting options available [13][24][25][39] Summary by Category Governance Revisions - The board has approved revisions to various governance documents, including the rules for board meetings, strategic committee guidelines, audit committee guidelines, nomination committee guidelines, compensation and assessment committee guidelines, independent director work systems, general manager work guidelines, and information disclosure management systems [1][2][3][4][5][6][7][8][9][10][11][12][20][21][22][23] - The revisions also include the management of major information reporting, external information submission, related party transaction decision-making, external guarantees, external investment, fundraising management, internal audit, and prevention of fund occupation by controlling shareholders [5][6][7][8][9][10][11][12][20][21][22][23] Shareholder Meeting - The company will convene the 2025 second extraordinary general meeting of shareholders on November 24, 2025, at 14:00, at its headquarters [13][24] - The meeting will utilize a combination of on-site and online voting methods, with specific time slots for online voting [24][25] - Shareholders must register to attend the meeting, with detailed registration procedures outlined [33][34][35][36][37][38]